Cargando…

Bone density in patients with late onset Pompe disease

BACKGROUND: Pompe disease is an inherited metabolic disorder characterized by α-glycosidase deficiency, which leads to lysosomal glycogen accumulation in many different tissues. The infantile form is the most severe with a rapidly fatal outcome, while the late onset form has a greater phenotypic var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadimas, George, Terzis, Gerassimos, Papadopoulos, Constantinos, Areovimata, Anna, Spengos, Konstantinos, Kavouras, Stavros, Manta, Panagiota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693639/ https://www.ncbi.nlm.nih.gov/pubmed/23843830 http://dx.doi.org/10.5812/ijem.4967

Ejemplares similares

Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease()
por: Papadopoulos, C., et al.
Publicado: (2013)

Functional capacity in a late-onset Pompe disease patient: Effect of enzyme replacement therapy and exercise training
por: Krase, Argyro A., et al.
Publicado: (2016)

An Age-Related Morphometric Profile of Skeletal Muscle in Healthy Untrained Women
por: Bougea, Anastasia, et al.
Publicado: (2016)

Hypothyroidism in late-onset Pompe disease
por: Schneider, Joseph, et al.
Publicado: (2016)

Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients
por: Sheng, Bun, et al.
Publicado: (2017)

Treatment Dilemma in Children with Late-Onset Pompe Disease
por: Faraguna, Martha Caterina, et al.
Publicado: (2023)

Late-Onset Pompe Disease with Nemaline Bodies
por: Frezza, E., et al.
Publicado: (2018)

Late-onset Pompe disease manifests in the brain
por: Finsterer, Josef
Publicado: (2019)

Pregnancy Outcomes in Late Onset Pompe Disease
por: Goker-Alpan, Ozlem, et al.
Publicado: (2020)

Erectile dysfunction and reduced libido in a myasthenia gravis patient treated with methotrexate
por: Papadopoulos, Constantinos, et al.
Publicado: (2021)

S1.5 Role of the pulmonologist in the late-onset Pompe disease
por: Fiorentino, Giuseppe, et al.
Publicado: (2011)

Analysis of voice quality in patients with late-onset Pompe disease
por: Szklanny, Krzysztof, et al.
Publicado: (2016)

Fatigue: an important feature of late-onset Pompe disease
por: Hagemans, M. L. C., et al.
Publicado: (2007)

Response: Late-onset Pompe disease manifests in the brain
por: Schneider, Ilka, et al.
Publicado: (2019)

Is the brain involved in patients with late‐onset Pompe disease?
por: van den Dorpel, Jan J. A., et al.
Publicado: (2022)

A Comprehensive Update on Late-Onset Pompe Disease
por: Labella, Beatrice, et al.
Publicado: (2023)

Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus
por: Fatehi, Farzad, et al.
Publicado: (2021)

Walking delay as leading symptom in late-onset Pompe disease
por: Gökce, S, et al.
Publicado: (2013)

Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014)

Bright tongue sign in patients with late-onset Pompe disease
por: Karam, Chafic, et al.
Publicado: (2019)

Dynamic respiratory muscle function in late-onset Pompe disease
por: Smith, Barbara K., et al.
Publicado: (2019)

COVID‐19 infection in patients with late‐onset Pompe disease
por: Avelar, Jennifer, et al.
Publicado: (2022)

Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement
por: Al-Hashel, Jasem, et al.
Publicado: (2022)

Facio-scapulo-humeral muscular dystrophy with early joint contractures and rigid spine
por: PAPADOPOULOS, CONSTANTINOS, et al.
Publicado: (2019)

Follow-up analysis of voice quality in patients with late-onset Pompe disease
por: Szklanny, Krzysztof, et al.
Publicado: (2018)

Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
por: Schoser, Benedikt
Publicado: (2013)

Quantitative analysis of upright standing in adults with late-onset Pompe disease
por: Valle, Maria Stella, et al.
Publicado: (2016)

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021)

Screening for late-onset Pompe disease in Internal Medicine departments in Spain
por: López-Rodríguez, Mónica, et al.
Publicado: (2023)

Update on Congenital Myopathies in Adulthood
por: Papadimas, George Konstantinos, et al.
Publicado: (2020)

Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion
por: Marotto, Daniela, et al.
Publicado: (2023)

Mobility assessment using wearable technology in patients with late-onset Pompe disease
por: Hamed, Alaa, et al.
Publicado: (2019)

Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures
por: Vanherpe, P., et al.
Publicado: (2020)

Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease
por: Tang, Shan, et al.
Publicado: (2021)

Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
por: Jackson, David G., et al.
Publicado: (2023)

Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing
por: Lévesque, Sébastien, et al.
Publicado: (2016)

Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
por: Zhang, Bin, et al.
Publicado: (2016)

Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease
por: Boentert, Matthias, et al.
Publicado: (2016)

Respiratory manifestations in late-onset Pompe disease: a case series conducted in Brazil
por: Sixel, Bruna de Souza, et al.
Publicado: (2017)

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
por: Byrne, Barry J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rt38nbd1g8a49chm75kb19o4he